Filing Details

Accession Number:
0001493152-20-000240
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-06 17:00:14
Reporting Period:
2020-01-02
Accepted Time:
2020-01-06 17:00:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1642380 Oncocyte Corp OCX Biological Products, (No Disgnostic Substances) (2836) CA
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
876343 Lineage Cell Therapeutics, Inc. 2173 Salk Avenue, Suite 200
Carlsbad CA 92008
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Disposition 2020-01-02 2,383,090 $2.16 6,041,154 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct